German Register of Outpatient Parenteral Antibiotic Therapy
试验速览
- 阶段
- 不适用
- 入组人数
- 600
- 试验地点
- 1
- 主要终点
- Number of Patients With Treatment-Related Adverse Events
研究概览
简要总结
Many infectious diseases require a therapy that is administered intravenously due to a lack of oral treatments. Affected patients often have to stay weeks or even months in hospital just for receiving their therapy although they do not feel severely unwell.
Outpatient parenteral antibiotic therapy (OPAT) allows these patients under certain requirements to get discharged from hospital and apply the antibiotic treatment on their own. For these patients quality of life improves by feeling more comfortable at home and being able to participate in everyday life or even go back to work. For the hospitals a reduced inpatient health care means a clear reduction of costs.
The aim of OPATReg is to examine under which conditions the OPAT can be established at different locations of patient care. For this purpose, patients with APAT are to be treated and data collected at 7 university institutions in Germany. All centers have the expertise to provide comprehensive care for patients with infectious diseases, to transfer them from inpatient to outpatient care and to continue to provide care there.
If successful, the project should help to identify the potential of OPAT for all of Germany. If positive effects and feasibility can be demonstrated OPAT could become an important therapy option with many advantages for certain patients.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •patients who get OPAT
排除标准
- •patients who don't get OPAT
结局指标
主要结局
Number of Patients With Treatment-Related Adverse Events
时间窗: 12 weeks
side-effects of treatment and catheter-related infections
Number of Hospitals being able to apply OPAT
时间窗: 12 weeks
Feasibility of OPAT under differing hospital specific circumstances
Number of Patients with effective OPAT
时间窗: 12 weeks
Successful administration and completion of the antiinfective therapy
次要结局
未报告次要终点
研究者
Clara Lehmann
Head of outpatient clinic
University of Cologne
